Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
PF-07820435 by Pfizer for Transitional Cell Carcinoma (Urothelial Cell Carcinoma): Likelihood of Approval
PF-07820435 is under clinical development by Pfizer and currently in Phase I for Transitional Cell Carcinoma (Urothelial Cell Carcinoma). According...
Data Insights
PF-07820435 by Pfizer for Non-Small Cell Lung Cancer: Likelihood of Approval
PF-07820435 is under clinical development by Pfizer and currently in Phase I for Non-Small Cell Lung Cancer. According to GlobalData,...